Etude double insu And NotJorge L. Juncos

List of bibliographic references

Number of relevant bibliographic references: 10.

Ident.	Authors (with country if any)	Title
000025	Claudio Pollo [Suisse] ; Alain Kaelin-Lang [Suisse] ; Markus F. Oertel [Suisse] ; Lennart Stieglitz [Suisse] ; Ethan Taub [Suisse] ; Peter Fuhr [Suisse] ; Andres M. Lozano [Canada] ; Andreas Raabe [Suisse] ; Michael Schüpbach [Suisse]	Directional deep brain stimulation: an intraoperative double-blind pilot study
000179	Bruno Dubois [France] ; Eduardo Tolosa [Espagne] ; Regina Katzenschlager [Autriche] ; Murat Emre [Turquie] ; Andrew J. Lees [Royaume-Uni] ; Gunther Schumann [Allemagne] ; Emmanuelle Pourcher [Canada] ; Julian Gray [Suisse] ; Gail Thomas [Royaume-Uni] ; Jina Swartz [Royaume-Uni] ; Timothy Hsu [États-Unis] ; Margaret L. Moline [États-Unis]	Donepezil in Parkinson's Disease Dementia: A Randomized, Double-Blind Efficacy and Safety Study
000366	Juliana Bronzova [Pays-Bas] ; Cristina Sampaio [Portugal] ; Robert A. Hauser [États-Unis] ; Anthony E. Lang [Canada] ; Olivier Rascol [France] ; Ad Theeuwes [Pays-Bas] ; Serge V. Van De Witte [Pays-Bas] ; Guus Van Scharrenburg [Pays-Bas]	Double-Blind Study of Pardoprunox, a New Partial Dopamine Agonist, in Early Parkinson's Disease
000498	C. Warren Olanow [États-Unis] ; Olivier Rascol [France] ; Robert Hauser [États-Unis] ; Paul D. Feigin [Israël] ; Joseph Jankovic [États-Unis] ; Anthony Lang [Canada] ; William Langston [États-Unis] ; Eldad Melamed [Israël] ; Werner Poewe [Autriche] ; Fabrizio Stocchi [Italie] ; Eduardo Tolosa [Espagne]	A Double-Blind, Delayed-Start Trial of Rasagiline in Parkinson's Disease
000917	Alan L. Whone [Royaume-Uni] ; Ray L. Watts [États-Unis] ; A. Jon Stoessl [Canada] ; Margaret Davis [États-Unis] ; Sven Reske [Allemagne] ; Claude Nahmias [Canada] ; Anthony E. Lang [Canada] ; Olivier Rascol [France] ; Maria J. Ribeiro [France] ; Philippe Remy [France] ; Werner Poewe [Autriche] ; Robert A. Hauser [États-Unis] ; David J. Brooks [Royaume-Uni]	Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL-PET study
000922	J. G. Nutt [États-Unis] ; K. J. Burchiel [États-Unis] ; C. L. Comella [États-Unis] ; Joseph Jankovic [États-Unis] ; A. E. Lang [Canada] ; E. R. Jr Laws [États-Unis] ; A. M. Lozano [Canada] ; R. D. Penn [États-Unis] ; R. K. Jr Simpson [États-Unis] ; M. Stacy [États-Unis] ; G. F. Wooten [États-Unis]	Randomized, double-blind trial of glial cell line-derived neurotrophic factor (GDNF) in PD
000C12	O. Rascol [France] ; D. J. Brooks [Royaume-Uni] ; A. D. Korczyn [Israël] ; P. P. De Deyn [Belgique] ; C. E. Clarke [Royaume-Uni] ; A. E. Lang [Canada]	A five-year study of the incidence of dyskinesia in patients with early parkinson's disease who were treated with ropinirole or levodopa
000C95	N. Galvez-Jimenez [Canada] ; A. Lozano [Canada] ; R. Tasker [Canada] ; J. Duff [Canada] ; W. Hutchison [Canada] ; A. E. Lang [Canada]	Pallidal stimulation in Parkinson's disease patients with a prior unilateral pallidotomy
000D19	R. Kumar [Canada] ; A. M. Lozano [Canada] ; Y. J. Kim [Canada] ; W. D. Hutchison [Canada] ; E. Sime [Canada] ; E. Halket [Canada] ; A. E. Lang [Canada]	Double-blind evaluation of subthalamic nucleus deep brain stimulation in advanced Parkinson disease
000D90	M. Guttman [Canada]	Double-blind comparison of pramipexole and bromocriptine treatment with placebo in advanced Parkinson's disease

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022